SUJAY KANGO

Insider Reports History

Location
Bridgewater, NJ
Signature
/s/ Adam M. Veness, as attorney-in-fact for Sujay Kango
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SUJAY KANGO:

Company Role Class Num Shares Value Price $ Report Date Ownership
INFINITY PHARMACEUTICALS, INC. Director Stock Option (right to buy) 90,000 30 Mar 2022 Direct
Dianthus Therapeutics, Inc. /DE/ Director Stock Option (Right to Buy) 25,000 04 Mar 2025 Direct
MEI Pharma, Inc. Director Stock Option (Right to Buy) 10,000 29 Sep 2023 Direct
ACCELERON PHARMA INC EVP, Chief Commercial Officer Common Stock 0 $29.37 19 Nov 2021 Direct
ACCELERON PHARMA INC EVP, Chief Commercial Officer Option to Purchase Common Stock 0 19 Nov 2021 Direct

Insider Reports Filed by SUJAY KANGO

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNTH Dianthus Therapeutics, Inc. /DE/ 04 Mar 2025 1 $0 4 Director 05 Mar 2025, 17:02
DNTH Dianthus Therapeutics, Inc. /DE/ 04 Mar 2025 0 $0 3 Director 05 Mar 2025, 17:01
MEIP MEI Pharma, Inc. 29 Sep 2023 1 $0 4 Director 12 Oct 2023, 19:39
MEIP MEI Pharma, Inc. 05 Jul 2022 1 $0 4 Director 07 Jul 2022, 16:19
INFI INFINITY PHARMACEUTICALS, INC. 30 Mar 2022 1 $0 4 Director 31 Mar 2022, 19:08
INFI INFINITY PHARMACEUTICALS, INC. 30 Mar 2022 0 $0 3 Director 31 Mar 2022, 18:46
MEIP MEI Pharma, Inc. 22 Nov 2021 1 $0 4 Director 23 Nov 2021, 14:22
MEIP MEI Pharma, Inc. 22 Nov 2021 0 $0 3 Director 23 Nov 2021, 14:20
XLRN ACCELERON PHARMA INC 19 Nov 2021 5 $0 4 EVP, Chief Commercial Officer 22 Nov 2021, 08:04
XLRN ACCELERON PHARMA INC 27 Sep 2021 3 -$671,950 4 EVP, Chief Commercial Officer 27 Sep 2021, 19:21
XLRN ACCELERON PHARMA INC 21 Sep 2021 3 -$547,100 4 EVP, Chief Commercial Officer 22 Sep 2021, 17:56
XLRN ACCELERON PHARMA INC 12 Feb 2021 1 -$116,082 4 EVP, Chief Commercial Officer 08 Jun 2021, 18:48